83 results
8-K
EX-99.1
ME
23andMe Holding Co - Ordinary Shares
8 Jan 24
Regulation FD Disclosure
7:45am
-selling health services Continued customer LTV and margin improvement Progress toward adjusted EBITDA breakeven Research collaborations New GWAS
8-K
ME
23andMe Holding Co - Ordinary Shares
10 Oct 23
Regulation FD Disclosure
4:17pm
Regulation FD Disclosure
23andMe Holding Co. (“23andMe,” “we,” “us,” and “our”) recently learned that certain profile information, which a customer … , loss of business, reputational damage adversely affecting customer relationships and investor confidence, U.S. regulatory investigations and enforcement
S-8
EX-99.1
ME
23andMe Holding Co - Ordinary Shares
15 Sep 23
Registration of securities for employees
4:06pm
typical adjustments consistently applied from GAAP required to determine economic value added performance measures); measures of customer satisfaction … , or the completion of other similar transactions intended to enhance the Company’s revenue or profitability or enhance its customer base; merger and acquisitions
8-K
EX-99.1
etcas96cezel y8bx
8 Aug 23
23andMe Reports FY2024 First Quarter Financial Results
4:10pm
DEFR14A
zavzw
4 Aug 23
Revised proxy
4:05pm
DEFR14A
nx5peziigftt4
26 Jul 23
Revised proxy
9:14pm
8-K
EX-99.1
iagcmbn23ki
25 May 23
23andMe Reports FY2023 Fourth Quarter and Full Year Financial Results
4:08pm
8-K
EX-99.1
zwvi391c1t wtdw
17 Apr 23
Regulation FD Disclosure
4:10pm
8-K
EX-99.1
3767m5jk4
9 Nov 22
Investor Presentation November 2022
7:30am
424B3
j38ujatrfbsb8u
7 Nov 22
Prospectus supplement
4:33pm
8-K
EX-99.1
lyivvyu
7 Nov 22
23andMe Reports FY2023 Second Quarter Financial Results
4:06pm
POS AM
tnupsktp
3 Nov 22
Prospectus update (post-effective amendment)
4:14pm
8-K
EX-99.1
n7zxd8bt
18 Aug 22
Investor Presentation August 2022
4:06pm